{
  "id": 3543027,
  "title": "Spyre tumbles as immune drug misses mark in rheumatoid arthritis",
  "url": "https://urgent.news/2026/08/26/spyre-tumbles-as-immune-drug-misses-mark-in-rheumatoid-arthritis",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-26T16:25:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/spyre-rheumatoid-arthritis-drug-study-results-skyway/828809/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The results erased more than $1 billion in market value and raised questions about how impactful drugs that block the TL1A protein might be against the condition.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}